Luyan Pharmaceutical: Net profit in 2025 was 281 million yuan, a year-on-year decrease of 18.74%.

Luyan Pharmaceuticals announced that its operating income in 2025 was 21.247 billion yuan, an increase of 3.79% year-on-year; net profit was 2.81 billion yuan, a decrease of 18.74% year-on-year. It plans to distribute a cash dividend of 3.5 yuan per 10 shares to all shareholders, without bonus shares or capitalization of reserves.